0001161697-21-000025.txt : 20210104
0001161697-21-000025.hdr.sgml : 20210104
20210104164221
ACCESSION NUMBER: 0001161697-21-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201230
FILED AS OF DATE: 20210104
DATE AS OF CHANGE: 20210104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tierney David S
CENTRAL INDEX KEY: 0001292636
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 21502302
MAIL ADDRESS:
STREET 1: C/O ABLE LABORATORIES, INC.
STREET 2: 6 HOLLYWOOD COURT, CN 1013
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1250
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1250
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 12-30-2020
X0306
4
2020-12-30
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001292636
Tierney David S
355 ALHAMBRA CIRCLE, SUITE 1250
CORAL GABLES
FL
33134
1
0
0
0
Options to purchase common stock
3.42
2020-12-30
4
A
0
30000
0
A
2027-12-30
Common Stock
30000
356167
D
Derivative securities vest in equal tranches, 1/3rd on December 30, 2021, 1/3rd on December 30, 2022 and 1/3rd on December 30, 2023.
/s/ David S. Tierney
2021-01-04